Ocata gets a SECOND NIH grant!!

I’m on the last day of vacation, so there won’t be a long post about this one, but basically… Ocata now has not one but TWO extremely recent NIH grants. This one is for Retinitis Pigmentosa. Now, I’m going to make a shameful admission… I’m an America’s Next Top Model addict. ;)ANTM doesn’t make it onto science blogs too often (or even science-y layperson blogs), but there’s a good reason here. Back in the fourth season, there was a contestant named Amanda. She was slowly going blind from Retinitis Pigmentosa, which is why I think the judges didn’t allow her to win. It was a very sad story and actually makes it hard to watch reruns of that season. By this time, I think she’s gone completely blind. But this grant shows that there is hope for her and everyone else who has the same terrible condition.

Anyway, check out the story:

Ocata Therapeutics Receives SBIR Grant from the NIH’s National Eye Institute to Develop Proprietary Photoreceptor Progenitor Cell Therapy for Retinitis Pigmentosa

Cathy Danielson
Follow me!

Cathy Danielson

In 2011, my life was shattered when I was diagnosed with a mysterious, incurable disease that always ends in blindness. The only hope on the horizon was a drug that broke all barriers in early testing. This drug, which replaces damaged cells in the eye, comes from the new class of stem cell based treatments that could cure the incurable, providing hope for patients with cancer, heart failure, ALS, cerebral palsy, and many more fatal and disabling diseases.

I survived the disease, and I now have the only remission on record. But a remission is not a cure. The stem cell drug I need for a real cure is now rapidly moving towards approval in the rest of the world, but in the USA, it—and all other cellular therapies-- are still stuck behind prejudice, ignorance, and lack of funding. Hundreds of millions of desperate patients with incurable diseases need these drugs.

That’s why I’ve gone on to fight for greater public education on stem cell drugs, knowing that our laws must be changed so that all of us can get access to the best treatments instead of our health and our lives being held hostage by special interests.

I’m now a patient advocate whose work on stem cells and patients’ rights has been published in outlets such as the Oregonian. I am a manager at popular science and financial blog www.stemcellinvestor.com and a frequent speaker at many venues across the spectrum, including churches, scientific conferences, and atheist groups, and everything in between. I’m also an advocate for Right to Try laws that would allow access to experimental medication for terminal patients at the state level. Read the entire story in my upcoming book, And the Blind Shall See: A Skeptic Patient Surprised by Faith, Science, Family, and Miracle Cures.
Cathy Danielson
Follow me!

Leave a Reply

Your email address will not be published. Required fields are marked *